Related Experiment Video
Updated: Mar 23, 2026
08:45
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
1.8K
Readmission in Cirrhosis: a Growing Problem
Sakkarin Chirapongsathorn1,2, Jayant A Talwalkar1, Patrick S Kamath3
1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN, 55905, USA.
Current Treatment Options in Gastroenterology
|April 3, 2016
Summary
Patients with cirrhosis face high readmission rates, posing burdens and negative outcomes. The Model for End-Stage Liver Disease (MELD) score and factors like frailty can help identify high-risk individuals for targeted interventions.
Area of Science:
- Hepatology
- Internal Medicine
- Health Services Research
Background:
- Cirrhosis patients experience frequent readmissions, increasing patient and healthcare burdens.
- Recent studies indicate high cirrhosis readmission rates and rising healthcare costs.
- Early identification of high-risk patients is crucial for effective management.
Purpose of the Study:
- To identify risk factors for hospital readmission in cirrhosis patients.
- To explore the utility of the Model for End-Stage Liver Disease (MELD) score for readmission risk stratification.
- To inform strategies for preventing readmissions in this population.
Main Methods:
- Review of existing literature on cirrhosis readmissions.
- Analysis of potential risk factors including MELD score, frailty, comorbidity, and socioeconomic status.
- Discussion of healthcare delivery system influences.
Main Results:
- High readmission rates are a significant issue for cirrhosis patients.
- The MELD score shows potential as a tool for risk stratification.
- Frailty, comorbidity, socioeconomic status, and healthcare system type are probable independent risk factors.
Conclusions:
- Proactive risk stratification at admission and dismissal is essential.
- Targeting high-risk cirrhosis patients with preventative strategies can reduce readmissions.
- Further research into specific interventions is warranted.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
740
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
740
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
333
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
333
01:24Liver Regeneration
4.7K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.7K
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
336
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
336
01:17Hepatic Drug Excretion: Enterohepatic Cycling
3.2K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.2K